Developing a European Registry for Rare Anaemias
|
|
- Myles Spencer
- 5 years ago
- Views:
Transcription
1 Developing a European Registry for Rare Anaemias Michael Angastiniotis Thalassaemia International Federation 6 th EUROPEAN SYMPOSIUM ON RARE ANAEMIAS 1 st Dutch-Belgian meeting for patients and health professionals 21 st - 22 nd November 2015 Amsterdam - The Netherlands
2 Disclosures - None Company name Research support Employee Consultant Stockholder Speakers bureau Advisory board Other
3 This talk is applicable for: Thalassemia s Sickle cell disease Definite Probable Membrane disorders (e.g. sferocytosis) Enzym defects (e.g. PKD, G6PD) PNH Other forms of hemolytic disease
4 Issues to be considered in planning services for rare anaemias Rare Present with symptoms to doctors who are not specialists Delay in diagnosis and wrong treatment Hereditary At risk families Preventable? Chronic Lifelong treatment needed Specialised and expensive care
5 Services required Specialised services to be made available Need for epidemiological data Centres of Expertise for reference Networks Reduction in complications and mortality
6 Why specialised services? Services are often developed by academic centres due to a research interest Patient s needs for chronic care is often a secondary consideration Multidisciplinary care is usually required Psychosocial support is always needed Comprehensive holistic care is essential Self management expert patients
7 Services required Specialised services to be made available Need for epidemiological data Centres of Expertise for reference Networks Reduction in complications and mortality
8 Need for epidemiological data Policy planning impossible without them How many patients? Where are they? Are there hot spots Is migration playing a role changing epidemiology Where to get information: Neonatal screening Population screening Hospital data after diagnosis paper or e-health record Specialist lab which confirmed the diagnosis These identify individual cases good record keeping essential
9 Examples from the late Herman Heimpel Heimpel et al European Journal of Haematology 2010,85,20-24
10 Services required Specialised services to be made available Need for epidemiological data Centres of Expertise for reference Networks Reduction in complications and mortality
11 The need for centres of expertise and what are they? Council Recommendation on the field of Rare Diseases criteria first identified & defined the EUCERD criteria They include: Capacity to diagnose correctly Manage patients with good outcomes Follow good practice guidelines Multidisciplinary care Research Involved in epidemiological surveillance Close collaboration with patient organisations Networking
12 Services required Specialised services to be made available Need for epidemiological data Centres of Expeertise for reference Networks Reduction in complications and mortality
13 The European Reference Networks ERN Project Indication of DG- SANCO interest and importance in RD service development Networking will facilitate: Pooling of knowledge in rare diseases experts to join their efforts to tackle complex or rare medical conditions Help patients and doctors find expert help and advice Facilitate cross border health Facilitate research for these rare conditions Facilitate EU collaboration
14 None of these services can be implemented without a registry Centre for Rare Diseases Bulgaria Prof. Rumen Stefanov 2011
15 What is a registry? Patient registries have been defined as an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves a predetermined scientific, clinical, or policy purpose(s) Ref: Glicklich R, Dreyer N. AHRQ Publ 10-EHC
16 Main functions of a registry Epidemiology and geo-mapping Clinical outcomes and natural history Quality of care and monitoring for improvements in care Research, including recruitment for clinical trials Policy development, Health planning Networking and cross border health A registry should be flexible so that adaptation or data mining can help with all these functions
17 EURORDIS NORD-CORD Joint declaration of 10 key principles for RD registries 1. Registry is a global priority 2. Encompassing the widest geographic scope even beyond Europe (see IRDiRC) 3. Registry is centred on a group of diseases 4. Interoprability based on international standards 5. A minimum set of Common Data Elements 6. Linking with biobank data 7. Patient reported data (not yet considered in our database) 8. Public Private partnerships to ensure sustainability 9. Patients are stakeholders in the database 10. Registries as instruments to empower patient communities
18 The architecture of then Enerca RA registry
19 The registry records the following Common data elements: agreed by EU agencies EPIRARE, EUCERD et al. Demographics, diagnosis (ICD10, Orphacode), Proof of diagnosis (optional) Family tree (optional) Patient outcomes: List of complications and when they occurred Date and cause of death Statistical package
20 Development of the Registry Consideration of confidentiality, patient ownership and the need for patient consent A review of the existing regulations and directives in the European Union concerning registries and health records. A study of the scientific basis of the standards and regulations through literature search. A study of already existing registries in the field of rare and/or chronic diseases. The result: an interoperable, extendible and functional database
21 Conclusion We are offering a comprehensive registry The need to comply with EU standards is an obligation Our task now is have the registry accepted at health provider, national and pan-eu levels Piloting starts soon and the final product is to be offered early next year
22 Thank you for listening This is a transfusion dependent thalassaemia patient in his 60s
EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)
EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) 31 January 2013 1 EUCERD RECOMMENDATIONS ON RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) INTRODUCTION 1. BACKGROUND TO
More informationEuropean Haemophilia Consortium
European Haemophilia Consortium Response to the European Commission Public Consultation on rare diseases: Europe s challenges The European Haemophilia Consortium 1 (EHC) is a European patient group representing
More informationEUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES
EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES 24 OCTOBER 2011 INTRODUCTION 1. THE EUROPEAN CONTEXT Centres of expertise (CE) and European Reference
More informationEuropean Reference Networks (ERN) Guide for patient advocates
European Reference Networks (ERN) Guide for patient advocates 1. European Reference Networks (page 1-3) a. What is an ERN? b. Who is a member of an ERN? c. Affiliated/ collaborative centres d. The IT platform
More informationERN Assessment Manual for Applicants
Share. Care. Cure. ERN Assessment Manual for Applicants 3.- Operational Criteria for the Assessment of Networks An initiative of the Version 1.1 April 2016 History of changes Version Date Change Page 1.0
More informationPolicies contributing to Health Reforms leading to improved management of Rare Diseases/ Anaemias/ Haemoglobin Disorders in Europe
Policies contributing to Health Reforms leading to improved management of Rare Diseases/ Anaemias/ Haemoglobin Disorders in Europe A. Eleftheriou, Ph.D Thalassaemia International Federation 4th European
More information2nd European Reference Networks Conference 8-9 October Lisbon, Portugal. A report by: G Porto & F Courtois
2nd European Reference Networks Conference 8-9 October Lisbon, Portugal A report by: G Porto & F Courtois (invited by EURORDIS) summary I INTRODUCTION What does a ERN mean? What will we (patients) gain
More informationERN board of Member States
ERN board of Member States Statement adopted by the Board of Member States on the definition and minimum recommended criteria for Associated National Centres and Coordination Hubs designated by Member
More informationMember webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016
Member webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016 1 What a European Reference Network is for us? Highly specialised healthcare networks meeting the needs
More informationEUCERD Joint Action WP7 Workshop From Centres of Expertise for Rare Diseases to European Reference Networks
EUCERD Joint Action WP7 Workshop From Centres of Expertise for Rare Diseases to European Reference Networks May 11-12 2014, Ministry of Health, Social Services and Equality, Madrid Spain. WP7 General Overview
More informationEU Health Programmes
Evaluation of the Health Programme 2008-2013 and Future actions under the new Health Programme 2014-2020 Michael Hübel Health Programme Management and Diseases DG Health and Consumers European Commission
More informationEuropean Reference Networks: strategic value for the Member States. Perspective of France
European Reference Networks: strategic value for the Member States Perspective of France Patrice Dosquet, MD Ministry of Health, France 2 European Reference Networks: Networks of healthcare providers/centres
More information1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?
Patient Safety p.1 Submission: 163 Stakeholder group Other other, please specify Hospital Country Germany Role in organisation management Number of employees 250 - Your organisation's geographical area
More informationBackground paper. Cross-border healthcare in the EU
Background paper Cross-border healthcare in the EU May 2018 1 Healthcare systems in Europe are under pressure because of an ageing population and budgetary constraints. Sometimes, the healthcare that citizens
More informationCouncil of the European Union Brussels, 8 September 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union
Council of the European Union Brussels, 8 September 2014 (OR. en) 12943/14 SAN 336 RECH 359 MI 637 COVER NOTE From: date of receipt: 5 September 2014 To: No. Cion doc.: Subject: Secretary-General of the
More informationRED CELL PATHOLOGY UNIT. HOSPITAL CLINIC-UNIVERSITY OF BARCELONA, Spain
RED CELL PATHOLOGY UNIT. HOSPITAL CLINIC-UNIVERSITY OF BARCELONA, Spain 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: 1. Respondent Profile Academic/public
More information1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?
Patient Safety p.1 Submission: 82 Name of organisation Mater Dei Hospital, Pathology Labs, MALTA Stakeholder group Member States authority Country MALTA Address Mater Dei Hospital, Tal- Qroqq, MSD 2090
More informationAN OPPORTUNITY FOR PRIMARY CARE
RARE DISEASES AN OPPORTUNITY FOR PRIMARY CARE Gerard Nguyen Primary Care, Cabinet Marcel Monny Lobe, Soisy sous Montmorency France Hopital Avicenne APHP Rett Syndrome Europe, AFSR, HUFERDIS (Hungary) RARE
More information9 Short Papers/ Presentations Key points are highlighted as follows;
Rare Voices Australia Rare Disease Registry Workshop 40 th HGSA (Human Genetics Society of Australasia) Annual Scientific Meeting, Post Conference Workshop, Hobart, Tasmania, Australia, 9 th August 2016
More informationVSOP, Lupus Netherlands
VSOP, Lupus Netherlands 1. Respondent Profile 1.1 Please indicate the type of organisation on behalf of which you are Public authorities and government-appointed bodies Please indicate level: National
More informationProposal for a new legal framework for data protection in EU
Proposal for a new legal framework for data protection in EU ENCePP Plenary Meeting 3 May 2012 Alessandro SPINA - EMA Data Protection Officer An agency of the European Union Background/1 In EU, legislation
More informationBELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)
BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD) Brussels, 19 October 2010 Summary Report Background and Objectives of the conference The Conference on Rheumatic and Musculoskeletal
More informationCross-Border Healthcare Intervention Trials in Ireland Network (CHITIN): PRE-ANNOUNCEMENT OF FUNDING CALL
Cross-Border Healthcare Intervention Trials in Ireland Network (CHITIN): PRE-ANNOUNCEMENT OF FUNDING CALL The Cross-Border Healthcare Intervention Trials in Ireland Network (CHITIN) project has been awarded
More informationDocument: Report on the work of the High Level Group in 2006
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL HIGH LEVEL GROUP ON HEALTH SERVICES AND MEDICAL CARE Document: Report on the work of the High Level Group in 2006 Date: 10/10/2006 To:
More informationPatient Registries Initiative Background, Achievements, Next steps
Patient Registries Initiative Background, Achievements, Next steps 21 November 2017 ENCePP Plenary meeting Presented by Xavier Kurz, Surveillance & Epidemiology Service, European Medicines Agency An agency
More informationThe Registry of Patient Registries (RoPR) Thomas Taylor, Senior IT Project Manager, Quintiles Michelle B. Leavy, Research Manager, Quintiles
The Registry of Patient Registries (RoPR) Thomas Taylor, Senior IT Project Manager, Quintiles Michelle B. Leavy, Research Manager, Quintiles February 10, 2014 Posting a Registry Profile on the RoPR What
More informationThe following passage wants to illustrate the insufficiencies in CF care the patients, their families and care giver struggle with:
Answer to SANCO 2007-07109-00-00-DE Tra-00 (EN) From Cystic Fibrosis Europe e.v. to DR SANCO Public Consultation regarding a European Action in the Field of Rare Diseases Cystic Fibrosis Europe is a federation
More informationCross Border Health: ERN-EuroBloodNet s overview for reaching equal access to care across EU MS
Cross Border Health: ERN-EuroBloodNet s overview for reaching equal access to care across EU MS Mariangela Pellegrini ERN Manager on behalf of ERN-EuroBloodNet Coordination Team Economical perspectives
More informationREFLECTION PROCESS on CHRONIC DISEASES INTERIM REPORT
REFLECTION PROCESS on CHRONIC DISEASES INTERIM REPORT A. INTRODUCTION REFLECTION PROCESS In conclusions adopted in March 2010, the Council called upon the Commission and Member States to launch a reflection
More informationImproving patients rights
U-Impact! From Citizen Involvement to EU Policy Impact Improving patients rights 18 th May 2016 Brussels EU Health policy (I) These principles and objectives support the goals of the Europe 2020 strategy
More informationUNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES
Association internationale sans but lucratif International non-profit organisation AVENUE DE LA COURONNE, 20 T +32 2 649 51 64 Discussion paper on European Reference Networks UEMS Meeting with European
More informationMaking the most of patient registries
Making the most of patient registries Elizabeth Hernberg-Ståhl M.Sc. Stockholm October 15 Late Phase Solutions Europe AB Rare Disease Research Forum- Challenges and Solutions Stockholm KI, February 21,
More informationERN Assessment Manual for Applicants 2. Technical Toolbox for Applicants
Share. Care. Cure. ERN Assessment Manual for Applicants 2. Technical Toolbox for Applicants An initiative of the Version 1.1 April 2016 1 History of changes Version Date Change Page 1.0 16.03.2016 Initial
More informationDefining an Outcome Measures Framework for Global Surgery
Defining an Outcome Measures Framework for Global Surgery Richard Gliklich MD Leffenfeld Professor of Otology and Laryngology, Harvard Medical School Surgeon, Mass Eye and Ear; Massachusetts General Hospital
More informationERN IT Platform delivering the virtual link for the Networks
3rd European Reference Networks Conference Vilnius, 9 March 2017 #ERNEU #Vilnius @EU_Health @EU_eHealth 1 / 16 Share.Care.Cure. ERN IT Platform delivering the virtual link for the Networks Tapani PIHA,
More informationThe Third EU Health Programme
The Third EU Health Programme With a focus on joint actions Stockholm, 22 August 2014 Dirk MEUSEL Scientific Project Officer European Commission Health and Food Exectutive Agency (Chafea) What's new? EAHC
More informationS. Tziaferi. President FOHNEU Assistant Professor in Community Nursing Dep. of Nursing University of Peloponnese
S. Tziaferi President FOHNEU Assistant Professor in Community Nursing Dep. of Nursing University of Peloponnese Occupational Health (OH) Occupational health has been described as the 'promotion and maintenance
More informationWORK PLAN 2017 LAURENCE BALLIEUX NATIONAL FOCAL POINT. 1 EU 3rd HEALTH PROGRAMME
1 EU 3rd HEALTH PROGRAMME 2014-2020 WORK PLAN 2017 LAURENCE BALLIEUX NATIONAL FOCAL POINT 2 3RD HEALTH PROGRAMME Published on 21 March 2014 4 overarching objectives: Promote health, prevent diseases and
More information1. Introduction, purpose of this Standard Operating Procedure (SOP)
SOP-CTN-001- Clinical Trial Network - General Organisation and Principles European Society of Anaesthesiology Details Document Type Document name Ref # Version Effective from Review date Owner Prepared
More informationState of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Denmark Report
State of the Art of Rare Disease - Activities in EU Member States and Other European Countries Definition of a Rare Disease Denmark Report Denmark has adopted the European Commission definition of a rare
More information1. Introduction, purpose of this Standard Operating Procedure (SOP)
Details Document Type Document name Ref # Version Effective from Review date Owner Prepared by Reviewed by Approved by Superseded documents Relevant regulations/legislation/guidelines/reference Standard
More informationAnnual Work Programme 2018
Annual Work Programme 2018 Infoday 30 January 2018 Irène ATHANASSOUDIS DG SANTE C1 The Health Programme Regulation EU N 282/2014 of 11 March 2014 Promoting health Encouraging innovation in health Complement,
More informationExecutive Report to the European Commission on newborn screening in the European Union
EU Tender Evaluation of population newborn screening practices for rare disorders in Member States of the European Union Executive Report to the European Commission on newborn screening in the European
More informationNational Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health
National Plans for Rare Diseases The French plan 2005-2008 2008 Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health Political Context Public Health Law of 9 August 2004 100
More informationNational Registriesfor Rare Diseases
National Registriesfor Rare Diseases Luciano Vittozzi National Centre for Rare Diseases, National Institute of Health Rome -Italy The currentsituation Registries serving 24 ERNs (to be developed) hospital-based
More informationDraft mandate Morbidity and Mortality Working Party
Draft mandate Morbidity and Mortality Working Party Luxembourg, 25.11.2003 1. Purpose of the Morbidity and Mortality Working Party (MMWP) The purpose of the Morbidity and Mortality Working Party (MMWP)
More information116 Help Lines for Rare Diseases
116 Help Lines for Rare Diseases François Houÿez Director of Health Policy Council of National Alliances, 29 October 2012, Paris Credits ENRDHL is one of the outcomes of the RAPSODY project supported by
More informationGlobal Diversity: Equity and Access
Global Diversity: Equity and Access Europe Annie Young Emerita Professor of Nursing, University of Warwick, UK Member, ISNCC Corporate and Philanthropic Committee Europe and the EU EU 28 27 countries BREXIT
More information1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?
Patient Safety p.1 Submission: 112 Name of organisation Registre des Ostéopathes de France Stakeholder group Other other, please specify Association Country France Address 8 Rue Thalès 33692 MERIGNAC CEDEX
More informationLessons from the EMA Patient Registries Initiative
Lessons from the EMA Patient Registries Initiative STAMP Commission Expert Group 8 th June 2018 Presented by Peter Arlett, with contributions from Patricia McGettigan and Jane Moseley Head of Pharmacovigilance
More informationUse of disease registries for benefitrisk evaluation of medicines: A regulatory perspective. DIA Europe April Basel, Switzerland
Use of disease registries for benefitrisk evaluation of medicines: A regulatory perspective DIA Europe 2018-17-19 April Basel, Switzerland Presented by Xavier Kurz Head of Service Surveillance and Epidemiology
More informationSummary. To assess the nurse's knowledge about children with thalassemia and assess the current nursing care given to children with thelassemia.
Summary Thalassaemia is the most, chronic hemolytic anemia in Egypt the estimated incidence of thalassemia heterozygote s ranges between 5.6 to 9%. In recent studies over 1000 children affected with β-thalassemia
More informationEuropean Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications
European Reference Networks Guidance on the recognition of Healthcare Providers and UK Oversight of Applications NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients
More informationMassachusetts Department of Public Health. Privacy of Health Data
Massachusetts Department of Public Health Privacy of Health Data Institutional Commitment to Privacy Privacy and Data Access Office Staffing Privacy Attorney Confidential Data Officer Admin Support Goals
More informationNational Strategies & Action for Rare Diseases in Europe
National Strategies & Action for Rare Diseases in Europe Paris, 18th November 2008 Opening Comments Roselyne BACHELOT-NARQUIN French Minister for Health, Youth and Sports I. Values Cooperation and solidarity
More informationMedical devices briefing for patients: Patient safety in the new Regulation
Medical devices briefing for patients: Patient safety in the new Regulation 20/12/2016 Patient safety is an important priority for the European Patients Forum, and it was also our main priority in our
More informationHTA and Patient Registries. Fedele (Duccio) Bonifazi
HTA and Patient Registries Fedele (Duccio) Bonifazi Health Technology Assessment Since available resources are limited, delivering health services involves making decisions. Decisions are required on what
More informationErasmus MC, Center for lysosomal and metabolic diseases, Netherlands
Erasmus MC, Center for lysosomal and metabolic diseases, Netherlands 1. Respondent Profile 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: Academic/public
More informationSpecialised Commissioning
Specialised Commissioning Improving specialised services for sickle cell, thalassaemia and other rare inherited anaemias What will this mean for patients and carers? What are the headlines? NHS England
More informationData Sources for Medical Device Epidemiology
Data Sources for Medical Device Epidemiology Kaiser Permanente Surgical Outcomes & Analysis Maria Inacio, PhD National Implant Registries Today s Talk* I. Necessary data elements for device surveillance
More informationConsultation: Transformation Health and Care in the Digital Single
Synopsis Report Consultation: Transformation Health and Care in the Digital Single Market Digital Single Market Prepared by the European Commission DG Communications Networks, Content & Technology and
More informationEUROPEAN COMMISSION HEALTH AND CONSUMER PROTECTION DG. Directorate C: Public Health and Risk Assessment Unit C2 - Health information
1 EUROPEAN COMMISSION HEALTH AND CONSUMER PROTECTION DG Directorate C: Public Health and Risk Assessment Unit C2 - Health information DRAFT SUMMMARY REPORT NINTH MEETING OF THE HEALTH SYSTEMS WORKING PARTY
More informationPORTUGAL FINAL REPORT
PORTUGAL EUROPLAN NATIONAL CONFERENCE FINAL REPORT 28 February, Lisbon FOREWORD The EUROPLAN National conferences are aimed at fostering the development of a comprehensive National Plan or Strategy for
More informatione-health LEGAL CHALLENGES
e-health LEGAL CHALLENGES European Integration and Healthcare Systems Brussels, 28 September 2007 Luba Hromkova Legal Officer Unit ICT for Health DG Information Society and Media (DG INFSO) EUROPEAN COMMISSION
More informationNorthwestern University Department of Urology
Northwestern University Department of Urology CONSENT FORM AND AUTHORIZATION FOR RESEARCH Title: Follow-Up Study of Northwestern University Prostate Cancer Patients of William J. Catalona, M.D. Principal
More informationBuilding the Europe of Knowledge
Building the Europe of Knowledge Investigación Europea en Cuidados de Salud Kevin McCarthy European Commission Public Health Research A science driven approach - Biotechnology, Agriculture... Biomedicine
More informationStatistical Analysis of the EPIRARE Survey on Registries Data Elements
Deliverable D9.2 Statistical Analysis of the EPIRARE Survey on Registries Data Elements Michele Santoro, Michele Lipucci, Fabrizio Bianchi CONTENTS Overview of the documents produced by EPIRARE... 3 Disclaimer...
More informationNeonatal Abstinence Syndrome Surveillance in West Virginia
Neonatal Abstinence Syndrome Surveillance in West Virginia Christina Mullins, Director Office of Maternal, Child and Family Health Bureau for Public Health West Virginia Department of Health and Human
More informationPatient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force
5 May 2017 EMA/180341/2017 Inspections, Human Medicines, Pharmacovigilance and Committees Division Patient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force EMA Initiative 1.
More informationGeneral Osteopathic Council
General Osteopathic Council Response to the European Commission Consultation regarding Community Action on health services Introduction The General Osteopathic Council (GOsC) is the competent authority
More informationUNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES
Association internationale sans but lucratif International non-profit organisation UEMS 2013/19 European Training Requirements for the Specialty of Occupational Medicine European Standards of Postgraduate
More informationActing Together: How to continue to provide high quality and universally accessible health services in a financially sustainable way in Europe.
Acting Together: A Roadmap for Sustainable Healthcare How to continue to provide high quality and universally accessible health services in a financially sustainable way in Europe. Recommendations and
More informationMDEpiNet RAPID Meeting
MDEpiNet RAPID Meeting BUILD, PCORnet & SENTINEL: Background, Data Model and Data Elements Jeffrey Brown, PhD Associate Professor May 25, 2017 1 FDA Sentinel: Background 2007: FDA Amendments Act A mandate
More informationTo broaden the horizon
To broaden the horizon Comparing Australian and Dutch healthcare for people with ID Willemijn Hensbroek Resident Intellectual Disability Medicine Content The Dutch ID Physician Demographics Housing and
More informationClinical Disease Registry Ontology for Blood Transfusion
ISBN 978-93-84468-11-8 Proceedings of 2014 International Conference on Artificial Intelligence & Manufacturing Engineering (ICAIME 2014) Dubai, December 25-26, 2014, pp. 185-190 Clinical Disease Registry
More informationEJA: EUCERD Joint Action: working for rare diseases Glória Isidro
INSA, I.P. Instituto Nacional de Saúde Dr. Ricardo Jorge EJA: EUCERD Joint Action: working for rare diseases Glória Isidro _Introduction Joint Action is a co-funded activity between European Commission
More informationEU OSH Strategic Framework & other initiatives
EU OSH Strategic Framework 2014-2020 & other initiatives Dr. Zinta Podniece Health, Safety and Hygiene at Work Unit EU-OSHA Seminar on psychosocial risks in Europe 17 October 2014, Brussels EU OSH Strategic
More informationDifferent dimensions of the ONCE-ONLY principle
Different dimensions of the ONCE-ONLY principle SEMIC 2015 Conference Riga - 5 May 2015 Mechthild Rohen European Commission, DG CONNECT Unit H3 - Public Services The Once-Only Principle (OOP) What are
More informationDo European Reference Networks fit national structures? A German perspective
Do European Reference Networks fit national structures? A German perspective European Hospital Conference Düsseldorf, 22 November 2013 (European Integration) Director EU-policies/international affairs
More informationWork Package 6 SKILLS AND COMPETENCIES NEEDED FOR THE CASE MANAGEMENT TRANING PROGRAMME. THE CURRICULA OF CASE MANAGER.
Work Package 6 SKILLS AND COMPETENCIES NEEDED FOR THE CASE MANAGEMENT TRANING PROGRAMME. THE CURRICULA OF CASE MANAGER. Graziano Onder Federica Mammarella AIFA Background II JA CHRODIS WP6 already achieved
More informationRegistries for Evaluating Patient Outcomes:
Registries for Evaluating Patient Outcomes: An Introduction to the User s Guide Michelle B. Leavy Managing Editor December 17, 2013 Copyright 2013 Quintiles Your Presenter Michelle Leavy, MPH Research
More informationInventory of Biological Specimens, Registries, and Health Data and Databases REPORT TO THE LEGISLATURE
Inventory of Biological Specimens, Registries, and Health Data and Databases REPORT TO THE LEGISLATURE MARCH 2017 1 Inventory of Biological Specimens, Registries, and Health Data and Databases February
More informationEuropean network of paediatric research (EnprEMA)
17 February 2012 EMA/77450/2012 Human Medicines Development and Evaluation Recognition criteria for self assessment The European Medicines Agency is tasked with developing a European paediatric network
More informationJOINT DECLARATION ON THE PROMOTION AND THE ENFORCEMENT OF CANCER PATIENTS RIGHTS
JOINT DECLARATION ON THE PROMOTION AND THE ENFORCEMENT OF CANCER PATIENTS RIGHTS Approved by the Association of European Cancer Leagues (ECL) in Oslo on June 28 th 2002 The contracting parties, PREAMBLE
More informationAccess to Microdata in EUROSTAT.
Access to Microdata in EUROSTAT http://ec.europa.eu/eurostat/web/microdata Legal Framework Regulation (EC) No 45/2001 on personal data protection (Ensuring citizens privacy) Some articles will not apply
More informationCommission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo
Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics 30.1.2017 Oslo 3.2.2017 O. Konttinen 1 Background Based on directive 2001/20/EC of the clinical trials on medicinal
More informationHorizon Public-Public Partnerships and the link to ERA
Horizon 2020 Public-Public Partnerships and the link to ERA Fabienne GAUTIER DG Research & Innovation Dir. B Innovation Union and European Research Area Unit B2 ERA Policy and Reforms ERA and Framework
More informationNewborn Screening Programmes in the United Kingdom
Newborn Screening Programmes in the United Kingdom This paper has been developed to increase awareness with Ministers, Members of Parliament and the Department of Health of the issues surrounding the serious
More informationAnalysis and a Review of Systematic Concept for Prevention and Health Promotion in Healthcare Sector of the Federation of Bosnia and Herzegovina
1452 Analysis and a Review of Systematic Concept for Prevention and Health Promotion in Healthcare Sector of the Federation of Bosnia and Herzegovina Vedran Đido 1*, Aida Ramić-Čatak 2 1 University of
More informationModule 2 Excellence in practice
Module 2 Excellence in practice This module sets out the key skills required by specialist nurses caring for patients with metastatic breast cancer. It also examines key interventions undertaken by nurses
More informationEPF recommendations for the trilogue on the proposal for regulation on Medical Devices
EPF recommendations for the trilogue on the proposal for regulation on Medical Devices Contents 1. Introduction... 3 2. EPF recommendations for the trilogue... 3 2.1 Gaps in Patient safety and quality
More informationLITHUANIA EUROPLAN NATIONAL CONFERENCE FINAL REPORT. Under the Lithuanian EU Presidency With an overview of ESTONIA and LATVIA Rare Disease Policies
LITHUANIA EUROPLAN NATIONAL CONFERENCE FINAL REPORT Under the Lithuanian EU Presidency With an overview of ESTONIA and LATVIA Rare Disease Policies 14 November 2013, Vilnius FOREWORD The EUROPLAN National
More informationData Protection Privacy Notice
Data Protection Privacy Notice Introduction This document explains why information is collected about you by the UK Renal Registry (UKRR) and how your information may be used this is called a Fair Processing
More informationNHS SCOTLAND APPLICATION FOR REIMBURSEMENT / PERMISSION TO TRAVEL FOR TREATMENT IN THE EUROPEAN ECONOMIC AREA
GUIDANCE NOTES This form can be completed by a person other than the patient, for example by a family member or a clinician. However, all the information provided should be about the patient. (Parts 8
More information2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE
2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN LATVIA This work was financed by the EUCERD Joint Action: Working for Rare Diseases
More informationList of Policies and Standard Operational Procedures (SOPs) for cell collection, processing and transplantation programmes
Format of SOPs (SOPs) for cell collection, processing and transplantation programmes There must be an SOP covering the procedure of preparing, implementing and revising all procedures and an SOP for document
More informationNational clinical audit of inpatient care for adults with ulcerative colitis
National clinical audit of inpatient care for adults with ulcerative colitis UK inflammatory bowel disease (IBD) audit Executive summary report June 2014 Prepared by the Clinical Effectiveness and Evaluation
More informationConfronting the Challenges of Rare Disease:
Confronting the Challenges of Rare Disease: SOLUTIONS ACROSS THE ENTIRE PRODUCT LIFE CYCLE The Orphan Drug Act of 1983 brought increased awareness to the need for new treatments for rare disease patients
More informationUK Renal Registry 20th Annual Report: Appendix A The UK Renal Registry Statement of Purpose
Nephron 2018;139(suppl1):287 292 DOI: 10.1159/000490970 Published online: July 11, 2018 UK Renal Registry 20th Annual Report: Appendix A The UK Renal Registry Statement of Purpose 1. Executive summary
More informationProf. Dr. Daniel Kotz 24 March 2017
Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care Prof. Dr. Daniel
More information